ESC Premium Access

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.

Congress Presentation

About the speaker

Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)
5 presentations
1 follower

4 more presentations in this session

Mediation analyses of the effect of ertugliflozin on hospitalisation for heart failure in patients with type 2 diabetes and atherosclerotic cardiovascular disease from the VERTIS CV trial

Speaker: Doctor M. Segar (Houston, US)

Thumbnail

Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis

Speaker: Doctor W. Sun (Shatin, HK)

Thumbnail

Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

Speaker: Doctor P. Myhre (Akershus, NO)

Thumbnail

Cardiorenal outcomes with ertugliflozin by baseline metformin use: post-hoc analyses of the VERTIS CV trial

Speaker: Doctor F. Cosentino (Stockholm, SE)

Thumbnail

Access the full session

Can we improve outcomes by targeting metabolic risk?

Speakers: Professor M. Banach, Doctor M. Segar, Doctor W. Sun, Doctor P. Myhre, Doctor F. Cosentino
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Future treatments for lipoprotein(a).

27 August 2021

ESC Premium Access

Repeat revascularization impact on 10-year survival after PCI or CABG: post-hoc analysis of the SYNTAXES trial

27 August 2021

ESC Premium Access

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

27 August 2021

ESC 365 is supported by

logo Novo Nordisk